FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:353-361 January 24, 2008 Number 4 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Supplementary Material Editorial by Starzl, T. E. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

SUMMARY

Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen. Transient chimerism and reversible capillary leak syndrome developed in all recipients. Irreversible humoral rejection occurred in one patient. In the other four recipients, it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation, and renal function has remained stable for 2.0 to 5.3 years since transplantation. The T cells from these four recipients, tested in vitro, showed donor-specific unresponsiveness and in specimens from allograft biopsies, obtained after withdrawal of immunosuppressive therapy, there were high levels of P3 (FOXP3) messenger RNA (mRNA) but not granzyme B mRNA.

Source Information

From the Transplantation Unit (T.K., A.B.C., N.T.-R., J.A.F., D.S.C.K., M.H., N.B.G., W.W., W.W.W.), Transplantation Biology Research Center (J.S., M. Sykes, D.H.S.), Bone Marrow Transplantation Program, Department of Medicine (T.R.S., B.D.), and Department of Pathology (S.L.S., F.I.P., R.B.C.), Massachusetts General Hospital, and Harvard Medical School, Boston; and the Division of Nephrology, Department of Medicine and Transplant Medicine, New York Presbyterian Hospital–Weill Cornell Medical Center, New York (M. Suthanthiran, R.D., V.S.).

Address reprint requests to Dr. Sachs at Massachusetts General Hospital Transplantation Biology Research Center, 149 13th St., Charlestown, MA 02129.

Full Text of this Article

This article has been cited by other articles:

• Bangham, A. (2009). The physical chemistry of self/non-self: jigsaws, transplants and fetuses. FASEB J. 23: 3644-3646 [Full Text]  
• Serafini, G., Andreani, M., Testi, M., Battarra, M., Bontadini, A., Biral, E., Fleischhauer, K., Marktel, S., Lucarelli, G., Roncarolo, M. G., Bacchetta, R. (2009). Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia. haematol 94: 1415-1426 [Abstract] [Full Text]  
• Noris, M., Cassis, P., Azzollini, N., Cavinato, R., Cugini, D., Casiraghi, F., Aiello, S., Solini, S., Cassis, L., Mister, M., Todeschini, M., Abbate, M., Benigni, A., Trionfini, P., Tomasoni, S., Mele, C., Garlanda, C., Polentarutti, N., Mantovani, A., Remuzzi, G. (2009). The Toll-IL-1R Member Tir8/SIGIRR Negatively Regulates Adaptive Immunity against Kidney Grafts. J. Immunol. 183: 4249-4260 [Abstract] [Full Text]  
• Janes, S., Dhaliwal, P., Wood, K. (2009). Tolerance in renal transplantation: is mixed chimerism the missing link?. Nephrol Dial Transplant 24: 1726-1729 [Full Text]  
• Miller, D. M., Thornley, T. B., Pearson, T., Kruger, A. J., Yamazaki, M., Shultz, L. D., Welsh, R. M., Brehm, M. A., Rossini, A. A., Greiner, D. L. (2009). TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade. J. Immunol. 182: 5547-5559 [Abstract] [Full Text]  
• Anglicheau, D., Sharma, V. K., Ding, R., Hummel, A., Snopkowski, C., Dadhania, D., Seshan, S. V., Suthanthiran, M. (2009). MicroRNA expression profiles predictive of human renal allograft status. Proc. Natl. Acad. Sci. USA 106: 5330-5335 [Abstract] [Full Text]  
• Geissler, E K, Schlitt, H J (2009). Immunosuppression for liver transplantation. Gut 58: 452-463 [Abstract] [Full Text]  
• Galliford, J, Game, D S (2009). Modern renal transplantation: present challenges and future prospects. Postgrad. Med. J. 85: 91-101 [Abstract] [Full Text]  
• Mansour, H., Homs, S., Desvaux, D., Badoual, C., Dahan, K., Matignon, M., Audard, V., Lang, P., Grimbert, P. (2008). Intragraft Levels of Foxp3 mRNA Predict Progression in Renal Transplants with Borderline Change. J. Am. Soc. Nephrol. 19: 2277-2281 [Abstract] [Full Text]  
• Luo, X., Pothoven, K. L., McCarthy, D., DeGutes, M., Martin, A., Getts, D. R., Xia, G., He, J., Zhang, X., Kaufman, D. B., Miller, S. D. (2008). ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc. Natl. Acad. Sci. USA 105: 14527-14532 [Abstract] [Full Text]  
• Griesemer, A. D., LaMattina, J. C., Okumi, M., Etter, J. D., Shimizu, A., Sachs, D. H., Yamada, K. (2008). Linked Suppression across an MHC-Mismatched Barrier in a Miniature Swine Kidney Transplantation Model. J. Immunol. 181: 4027-4036 [Abstract] [Full Text]  
• Fehr, T., Wang, S., Haspot, F., Kurtz, J., Blaha, P., Hogan, T., Chittenden, M., Wekerle, T., Sykes, M. (2008). Rapid Deletional Peripheral CD8 T Cell Tolerance Induced by Allogeneic Bone Marrow: Role of Donor Class II MHC and B Cells. J. Immunol. 181: 4371-4380 [Abstract] [Full Text]  
• Chino, T., Tamai, K., Yamazaki, T., Otsuru, S., Kikuchi, Y., Nimura, K., Endo, M., Nagai, M., Uitto, J., Kitajima, Y., Kaneda, Y. (2008). Bone Marrow Cell Transfer into Fetal Circulation Can Ameliorate Genetic Skin Diseases by Providing Fibroblasts to the Skin and Inducing Immune Tolerance. Am. J. Pathol. 173: 803-814 [Abstract] [Full Text]  
• Huang, X., Moore, D. J., Ketchum, R. J., Nunemaker, C. S., Kovatchev, B., McCall, A. L., Brayman, K. L. (2008). Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation. Endocr. Rev. 29: 603-630 [Abstract] [Full Text]  
• Giassi, L. J., Pearson, T., Shultz, L. D., Laning, J., Biber, K., Kraus, M., Woda, B. A., Schmidt, M. R., Woodland, R. T., Rossini, A. A., Greiner, D. L. (2008). Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2r{gamma}null Mice. Exp. Biol. Med. 233: 997-1012 [Abstract] [Full Text]  
• Porrett, P. M., Yuan, X., LaRosa, D. F., Walsh, P. T., Yang, J., Gao, W., Li, P., Zhang, J., Ansari, J. M., Hancock, W. W., Sayegh, M. H., Koulmanda, M., Strom, T. B., Turka, L. A. (2008). Mechanisms Underlying Blockade of Allograft Acceptance by TLR Ligands. J. Immunol. 181: 1692-1699 [Abstract] [Full Text]  
• Fehr, T., Haspot, F., Mollov, J., Chittenden, M., Hogan, T., Sykes, M. (2008). Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class II. J. Immunol. 181: 165-173 [Abstract] [Full Text]  
• Traum, A. Z., Kawai, T., Vacanti, J. P., Sachs, D. H., Cosimi, A. B., Madsen, J. C. (2008). The Need for Tolerance in Pediatric Organ Transplantation. Pediatrics 121: 1258-1260 [Full Text]  
• Starzl, T. E. (2008). Immunosuppressive Therapy and Tolerance of Organ Allografts. NEJM 358: 407-411 [Full Text]